Neurocrine Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for NEUROCRINE, and what generic alternatives to NEUROCRINE drugs are available?
NEUROCRINE has two approved drugs.
There are twenty-nine US patents protecting NEUROCRINE drugs.
There are two hundred and eighty-three patent family members on NEUROCRINE drugs in forty-two countries and nineteen supplementary protection certificates in sixteen countries.
Summary for Neurocrine
| International Patents: | 283 |
| US Patents: | 29 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Neurocrine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neurocrine | INGREZZA | valbenazine tosylate | CAPSULE;ORAL | 209241-001 | Apr 11, 2017 | RX | Yes | No | 10,952,997 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Neurocrine | INGREZZA | valbenazine tosylate | CAPSULE;ORAL | 209241-002 | Oct 4, 2017 | RX | Yes | Yes | 11,026,939 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Neurocrine | ONGENTYS | opicapone | CAPSULE;ORAL | 212489-001 | Apr 24, 2020 | RX | Yes | No | 8,168,793 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Neurocrine Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Cyprus | 1122580 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2016083863 | ⤷ Try a Trial |
| China | 115322188 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Neurocrine Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1907382 | 1690058-1 | Sweden | ⤷ Try a Trial | PRODUCT NAME: OPICAPONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/15/1066 20160628 |
| 1907382 | 706 | Finland | ⤷ Try a Trial | |
| 1907382 | 57/2016 | Austria | ⤷ Try a Trial | PRODUCT NAME: OPICAPON ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/15/1066 (MITTEILUNG) 20160628 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
